A research team has identified the impact of stem cell infusion timing on the incidence and severity of acute ...

A research team led by Prof. ZHAN Cheng from the University of Science and Technology of China (USTC), and Chief Physician ZHU Xiaoyu from the First Affiliated Hospital of USTC has identified how stem ...

The company’s president and head of research and development, Dr Maria Grazia Roncarolo, is leading the trial.

The Phase 4 ENABLE study is set to be first in the U.S. to collect real-world safety and efficacy data of Briumvi for ...

A therapy using a patient's own proximal basal stem cells shows promise to treat idiopathic pulmonary fibrosis.

A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a CD30/CD16A bispecific antibody, was safe and generated strong response rates ...